Aurinia Pharmaceuticals Inc. (AUPH)


Stock Price Forecast

April 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Aurinia Pharmaceuticals Inc. chart...

About the Company

We do not have any company description for Aurinia Pharmaceuticals Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

337

Exchange

Nasdaq

$66M

Total Revenue

337

Employees

$725M

Market Capitalization

-7.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AUPH News

Aurinia Pharmaceuticals to release Q1 earnings report May 2

Opinion ago, source: The Daily Record (Maryland)

Listen to this article Aurinia Pharmaceuticals Inc. Monday announced that it will release financial and operational results ...

When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?

8d ago, source:

With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals Inc.'s ...

Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program

1mon ago, source: Stockhouse

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Canadian securities regulators have granted exemptive relief for the Company’s share ...

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

7d ago, source:

ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference ...

AUP:CA Aurinia Pharmaceuticals Inc.

20d ago, source: Seeking Alpha

* EPS estimates are GAAP unless otherwise noted.

Aurinia Pharmaceuticals Inc. (IKAP.F)

1mon ago, source: Yahoo Finance

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript February 15, 2024 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations ...

Aurinia Pharmaceuticals Inc AUPH

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aurinia Pharmaceuticals Inc.

19d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aurinia Pharmaceuticals Inc (AUPH)

2mon ago, source: Investing

Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic ...

AUPH Aurinia Pharmaceuticals Inc.

24d ago, source: Seeking Alpha

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...